Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 2 2015

Print

Search Results for 'Bio News'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published May 21, 2015
Selected for a highly specialized vaccine fill/finish project Read More »
Published May 19, 2015
Company continues to support its growing biologics portfolio Read More »
Published May 12, 2015
Will support commercial-scale ADC manufacturing Read More »
Published May 12, 2015
Gains leading biologic treatment and oncology infrastructure for $900M Read More »
Published May 11, 2015
The new facility has already been deployed to manufacture a Humira biosimilar candidate in an upcoming Phase III trial Read More »
Published May 8, 2015
Additional 27,000 sq.-ft. will supply materials for clinical trials Read More »
Published April 30, 2015
Will be among the largest mammalian cell culture mfg. facilities using disposable bioreactors Read More »
Published March 27, 2015
Launch of first etanercept biosimilar reduces the cost of treatment down to 50 percent Read More »
Laurus Synthesis Launches US Operations
Published March 20, 2015
Opens facility in Woburn, MA Read More »
Published March 20, 2015
$30 million investment in biotechnology will create up to 100 new jobs Read More »
Published March 12, 2015
Adds Sensors for Flow Rate Measurement Read More »
Published March 12, 2015
Will provide cGMP manufacture for clinical and commercial supply Read More »
Published March 9, 2015
Sandoz Zarxio approved for all indications on Filgrastim label Read More »
Published March 6, 2015
CoE in San Diego has 46,000 sq.-ft. of lab, office and sample storage space Read More »
Published March 2, 2015
Integrates continuous flow manufacturing technology Read More »
Published February 19, 2015
Will manufacture GMP Cymerus MSC product for clinical and collaboration programs Read More »
Published November 21, 2014
Increased production capacity to support maturing biologics pipeline Read More »
Published November 14, 2014
The investment, upwards of $900 million, will support multiple therapies Read More »
Published November 13, 2014
Roche instruments expand capacity for high-throughput DNA studies Read More »
Published October 23, 2014
Contract manufacturing market has grown 10% the past three years Read More »
Published October 7, 2014
Offers a range of advanced biomedical technologies for clinical and commercial volumes Read More »
Published October 2, 2014
Further expands SMARTag Antibody-Drug Conjugate (ADC) technology platform Read More »
Published September 30, 2014
Will begin providing dedicated biologics services in the U.S Read More »
Published September 12, 2014
Aims to meet clinical development needs for all therapeutic areas Read More »
Published September 9, 2014
Plans to double its workforce Read More »
Published August 27, 2014
Training center to aid biopharma companies with manufacturing challenges Read More »
Published August 7, 2014
Will support the processing of ADVATE Read More »
Published May 13, 2014
Expands platform of biologics services Read More »
Published May 7, 2014
Plans further investments in promising start-ups Read More »
Published May 5, 2014
To provide upstream services at Billerica facilities Read More »
Published April 28, 2014
Expands portfolio of single-use components for biopharma applications Read More »
Published April 9, 2014
Shows partnership activity up 34% in 2013 Read More »
By Kristin Brooks
Published March 21, 2014
Will evaluate VELTIS technology for potential drug candidates Read More »
By Kristin Brooks
Published March 21, 2014
Will use POTELLIGENT CHOK1SV for antibody development Read More »
By Kristin Brooks
Published March 21, 2014
Adds biopharma assessment services Read More »
By Kristin Brooks
Published March 14, 2014
Will leverage SmartFactory single-use automation platform Read More »
By Kristin Brooks
Published March 7, 2014
To manufacture mAb using GPEx technology for a clinical research project Read More »
By Kristin Brooks
Published March 4, 2014
Will use the technology to enhance the ADCC activity lead product Read More »
By Kristin Brooks
Published March 4, 2014
Opens corporate headquarters and R&D facility Read More »
By Kristin Brooks
Published February 20, 2014
Aims to advance synthetic biology research technologies Read More »
By Gil Roth
Published February 18, 2014
Expands ADC characterization Read More »
By Gil Roth
Published February 18, 2014
Will provide mammalian, microbial services to clinical-stage company Read More »
By Kristin Brooks
Published February 5, 2014
Doubles capacity for analysis of biosimilar monoclonal antibodies Read More »
By Gil Roth
Published February 5, 2014
Botox, eye care drugs fuel growth Read More »
By Andrew Badrot, CMS Pharma
Published January 30, 2014
DSM & Patheon unlock value through a creative merger Read More »
By Gil Roth
Published January 30, 2014
Oncology drugs fuel growth Read More »
By Gil Roth
Published January 30, 2014
Soliris sales continue to climb Read More »
By Kristin Brooks
Published January 29, 2014
To produce a new class of APIs called viral vectors Read More »
By Kristin Brooks
Published January 28, 2014
Studies will be conducted at newly expanded labs in Wokingham Read More »
By Gil Roth
Published January 13, 2014
Ampio, Galectin, Generex, Gilead, Merck, The Medicines Company Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On